Prolacta Bioscience   Report issue

For profit Phase 2
Founded: City of Industry CA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2007
NCT00506584
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Prolacta Bioscience | Vice President, Medical Affairs, Prolacta Bioscience

Active Ingredients

Drugs in Phase 2 Trials (2)

bifidobacterium infantis (1 trial)

human milk (8 trials)

Drugs in Other Trials (1)

cow milk (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 3